CEACAM5 and neoplasm: By comparing the changes in GGT and CEA levels before and after NAC, it can help forecast the tumor’s response to chemotherapy, thus preventing patients with poor NAC efficacy from undergoing premature surgery or receiving excessive NAC treatment.